ESR1 and breast cancer: In addition, recent genome-wide mapping of FOXM1 binding by chromatin immunoprecipitation with massively parallel DNA sequencing (ChIP-seq) analysis reveals the co-binding of FOXM1 with ERα in breast cancer cells, suggesting that FOXM1 is a common co-factor of ERα [84].